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 First report of uropathogenic Escherchia coli ST58 (strain 2009-52) from a patient with urosepsis 
 Illumina and Single Molecule, Real-Time (SMRT) sequencing used to characterise strain 2009-52 
 Strain 2009-52 carries IncF plasmid pSDJ2009-52F with antimicrobial resistance and virulence 
genes 
 pSDJ2009-52F  carries an atypical class 1 integron and Tn6029 within a novel Tn2610-like 
transposon  
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ST58 phylogroup B1 E. coli have been isolated from a wide variety of mammalian and avian hosts but are 
not noted for their ability to cause serious disease in humans or animals. Here we determined the genome 
sequences of two multiple drug resistant ST58 Escherichia coli strains from urine and blood of one patient 
using a combination of Illumina and Single Molecule, Real-Time (SMRT) sequencing. Both ST58 strains 
were clonal and were characterised as serotype O8:H25 phylogroup B1 and carried a complex resistance 
locus/loci (CRL) that featured an atypical class 1 integron with a dfrA5 (trimethoprim resistance) gene 
cassette followed by only 24 bp of the 3´-CS.  CRL that carry this particular integron have been described 
previously in E. coli from cattle, pigs and humans in Australia. The integron abuts a copy of Tn6029, an 
IS26-flanked composite transposon encoding blaTEM, sul2, strAB genes that confer resistance to ampicillin, 
sulphathiazole and streptomycin respectively. The CRL resides within a novel Tn2610-like hybrid 
Tn1721/Tn21 transposon on an IncF, colV plasmid (pSDJ2009-52F) of 138,553 bp that encodes virulence 
associated genes (VAGs) implicated in life threatening ExPEC infections. Notably, pSDJ2009-52F shares 
high sequence identity with pSF-088-1, a plasmid reported in an E. coli ST95 from a patient with blood 
sepsis from a hospital in San Francisco. Our data suggest that extraintestinal infections caused by E. coli that 
carry colV-like plasmids, irrespective of their phylogroup or MLST, may pose a potential threat to human 
health, particularly to the elderly and the immunocompromised. 
 























Extraintestinal pathogenic Escherichia coli (ExPEC) are a phylogenetically diverse group of E. coli that 
have acquired the ability to colonise anatomical sites distinct from the gastrointestinal tract including the 
urinary tract, brain and spinal cord, soft tissue sites and bone. ExPEC are classified into three subtypes that 
include uropathogenic E. coli (UPEC), neonatal meningitis associated E. coli (NMEC) and avian pathogenic 
E. coli (APEC) 
1
. ExPEC also cause nosocomial bloodstream infections in hospitals and nursing homes and 
are often responsible for respiratory infections and bacteraemia in long-term hospitalized patients. ExPEC 
have been identified in humans, food animals, retail meat products, companion animals and effluent and 





Our understanding of the evolution and spread of multiple antibiotic resistance in ExPEC has been 
influenced by efforts to gauge the prevalence of E. coli expressing extended spectrum β-lactamases (ESBL), 
Amp C β-lactamases and plasmid-mediated quinolone and fluoroquinolone resistance. Knowledge of the 
extent of the carriage of antibiotic resistance genes is likely to be underestimated because many studies 
restrict phenotypic screening to antibiotics that are of clinical relevance for infection control. As a 
consequence, resistance to older first generation antibiotics, many of which are still used in veterinary 
medicine and food production more broadly; particularly ampicillin, sulfonamides, tetracycline and 
trimethoprim, is ignored. 
 
IS26 plays a critical role in the capture and dissemination of broad classes of antimicrobial resistance 
genes including genes encoding resistance to all last line antibiotics.  IS26 is widespread in commensal and 
pathogenic E. coli from food animals in Australia 
5, 6
 and it often localizes to sites that are within close 
genetic proximity to class 1 integrons and facilitates formation of complex resistance loci (CRL) on 
transposons and plasmids 
5, 7-13
. IS26 can promote the generation of hybrid plasmids carrying antibiotic 
resistance and virulence genes 
14
, as well as influence plasmid fitness by deleting regions of DNA that 
encode genes whose expression incurs a cost to the host 
15












IS26 are targeted by mobile genetic cargo flanked by IS26 enabling host bacteria to adapt rapidly to an 
antimicrobial selection pressure. Clearly it is important to understand how CRL encoding resistance to first 
generation antibiotics, and the mobile elements that carry them, have evolved and to determine how 
widespread they are in commensal and pathogenic E. coli and other Gram negative pathogens that are 
exposed to antimicrobial selection pressures in human healthcare, food animal production settings and the 
environment. 
 
Here we characterized two UPEC isolates from an elderly patient collected four days apart. Strain 2009-49 
was from midstream urine and strain 2009-52 was from blood. The aim of this study was to use whole gene 
sequencing (WGS) to determine the genetic relation they shared to one another and to isolates belonging to 
the same MLST, their repertoire of antibiotic resistance and virulence associated genes, and the plasmids 
they carry.  
 
2. Materials and Methods 
2.1 Bacterial strains 
Both ST58 strains from this study were sourced from Sydney Adventist Hospital in 2009. Strain 2009-49 
was cultured from the mid-stream urine of an elderly patient presenting with a urinary tract infection and 
strain 2009-52 was cultured from a blood sample obtained from the same patient four days later. The 
pathology report indicated that the patient had elevated leukocytes and red blood cells and a high bacterial 
colony count. The urinary tract isolate 2009-49 displayed resistance to ampicillin, trimethoprim and 
nitrofurantoin while the blood isolate was recorded as being resistant to ampicillin. 
 
2.2 Calibrated Dichotomous Sensitivity (CDS) Testing 
Antibiotic susceptibility testing was performed using the established CDS protocol. Strains 2009-49 and 
2009-52 and the three reference strains E. coli ACM 5185 and 5186 and Pseudomonas aeruginosa ACM 
5189 137 were grown overnight on LB agar plates at 37°C. Antibiotic discs were applied to Sensitest 
(Oxoid®) plates at a maximum of 6 per plate using a 6-Cartridge Disc Dispenser (Oxoid®). Strains were 












(amoxicillin/clavulanate; 6 μg), azithromycin (15 μg), cefotaxime (5 μg), cefoxitin (30 μg), cephalexin (100 
μg), chloramphenicol (30 μg), ciprofloxacin (2.5 μg), gentamicin (10 μg), imipenem (10 μg), kanamycin (50 
μg), nalidixic acid (30 μg), neomycin (30 μg), nitrofurantoin (200 μg), streptomycin (25 μg), sulfafurazole 
(300 μg), tetracycline (10 μg), timentin (ticarcillin/clavulanate; 85 μg) and trimethoprim (5 μg). 
 
2.3 Whole Genome Sequencing and Analyses 
Whole genome sequencing was performed using an Illumina® MiSeq platform at the ithree institute, 
University of Technology Sydney following published protocols and raw reads were assembled using the A5 
de novo assembly pipeline 
16
. Sequence typing was performed electronically using the E. coli Achtman 
MLST scheme available at https://pubmlst.org/. Plasmid classification was determined by submission of 
whole genomes to PlasmidFinder 1.2 (https://cge.cbs.dtu.dk/services/PlasmidFinder/).  
 
SMRT sequencing was performed on strain 2009-52 using a Pacific Biosystems RSII instrument and HGAP 
assembly at the Ramaciotti Centre at the University of New South Wales, Sydney, Australia. The sequence 
was polished using Pilon (https://github.com/broadinstitute/pilon). A phylogenetic tree was constructed with 
326 complete genome sequences of E. coli obtained from Enterobase. PhyloSift v1.0 
(http://phylosift.wordpress.com/) was used to undertake the phylogenetic analysis and the output was 
manipulated using FigTree (http://tree.bio.ed.ac.uk/software/figtree/). Phylosift analysis was used to 
determine the genome sequence most closely related to ST58 strains 2009-49 and 2009-52. 
 
2.4 Single Nucleotide Polymorphisms (SNP) 
Parsnp from the Harvest Tools suite (https://harvest.readthedocs.io/en/latest/content/harvest-tools.html) was 
used to identify SNPs in the core genomes of 2009-49 (Miseq) and 2009-52 (PacBio), by aligning the 
genomes with the most closely related complete reference genome, SCK30-22, available in Enterobase. x 
flag was implemented to filter out recombination events, which resulted in alignment of 82.2% of the three 
genomes. Gingr 
17
 was used to visualise the SNP locations in the .ggr file and the matching co–ordinates 












confirmed by BLASTn analysis and subjected to SIFT (http://sift.jcvi.org/www/SIFT_seq_submit2.html)
 
analysis to assess functional alterations in protein function. 
 
Nucleotide sequence accession numbers 
Strains 2009-49 and 2009-52 and plasmid pSDJ2009-52F have been submitted to GenBank under accessions 
NXEP00000000, NXEO00000000 and MH195200 respectively. 
 
 
3. Results and Discussion 
Uropathogenic E. coli strain 2009-49 (urine isolate) and 2009-52 182 (blood isolate) were sourced from the 
same patient within a narrow time frame (4 days). Available metadata indicated both strains were resistant to 
ampicillin, trimethoprim and nitrofurantoin. CDS assays revealed both strains showed reduced susceptibility 
to ampicillin, trimethoprim, sulfafurazole, tetracycline and streptomycin. eMLST analysis identified both 
strains as ST58, a sequence type that resides within the ST155 clonal complex. Both strains were Clermont 
phylotype B1, were serotyped in silico as O8:H25, and carried plasmid incompatibility markers F and FIB. 
Strain 2009-52 also carried an I2 replicon. 
 
3.1 Whole Genome Sequencing and Comparative Genomic Analyses 
Assembly statistics for the two genomes are presented in Table S1. A proportional phylogenetic cladogram 
generated using Phylosift, comprising genome sequences of isolates 2009-49 and 2009-52 and 84 ST58 E. 
coli genomes of human and animal origin from Enterobase is shown in Figure 1. A more comprehensive 
phylogenetic tree of ST58 genomes is shown in Figure S2. 2009-49 and 2009-52 clustered together with a 
node confidence value of 1. The closest relative to the Sydney ST58 strains was strain SCK30-22, an ST58, 
serotype O8:H25 E. coli, sourced from an undisclosed human infection from the Netherlands. Strain SK30-
22 was used to extract the core genome of our two ST58 strains and identify SNPs between them. Only four 
SNPs, all but one (fimG; S167R) of which were silent, was identified using Parsnp and Gingr from the 
Harvest Tools suite. Three SNPs that 2009-52 housed in comparison to 2009-49 and the reference, were 












within a predicted transposase in strain 2009-49. The low number of SNPs is consistent with the two Sydney 
ST58 strains being clonal. SMRT sequencing showed that strain 2009-52 had a chromosome comprising 
5,012,036 nucleotides and two plasmids: IncI2 plasmid pSDJ2009-52I2 (215,832 bp) and IncF plasmid 
pSDJ2009-52F (138,553 bp). 
 
A whole genome BLASTn analysis using strain 2009-52 genome as the query and 2009-49 (Figure S3) 
identified a 215,832 nt plasmid (pSDJ2009-52I2) scaffold (Figure S4) in strain 2009-52 but not 2009-49.  
pSDJ2009-52I2 carries a putative Type IV secretion system (T4SS) (virD4, virB1, virB2, virB4-B6 and vir8-
11), phage related genes, pilin genes (pilN, pilO, pilP, pilQ, pilR, pilS, pilT, pilU and pilV), and 36 
hypothetical genes. Coding sequences in pSDJ2009-5212 are shown in Table S5. 
 
3.2 Virulence associated genes (VAGs) in ST58 strains 
Strains 2009-49 and 2009-52 carry fimbrial adhesins including bmaE, fimH, gafD, csgG and yfcV, multiple 
iron acquisition operons, several copper resistance genes, toxins including hlyE, hlyF and hek, and various 
membrane-associated pumps and proteases (Table 1).  
 
3.3 Characterisation of the complex resistance locus (CRL) in the Sydney ST58 strains 
Both 2009-49 and 2009-52 possess an atypical class 1 integron carrying a dfrA5 gene cassette (trimethoprim 
resistance) missing all but 24 bp of the 3´-CS. Genetic signatures such as these can be useful to track the 
plasmids and transposons 
5, 10
. A PCR with a forward primer in intI1 and a reverse primer in IS26, developed 
previously to characterise atypical class 1 integrons 
5
 generates an amplicon of 848 bp. An identical 848 bp 
signature is observed in derivate Tn21-associated CRL of MDR O26 enterohaemorrhagic E. coli (EHEC) 
from a human and serologically diverse atypical enteropathogenic E. coli (EPEC) from Australian cattle 
5, 12, 
13
 and in commensal E. coli from swine 
6
. The presence of the same signature in UPEC suggests that the 
Tn21 transposon, and the plasmids that carry it, are disseminated widely in animal production systems in 
Australia. The molecular signature is created by an IS26-mediated deletion caused by insertion of IS26 
5
 or 
IS26-flanked transposons such as Tn6029, into the backbone of mercury resistance transposons belonging to 
the Tn3 family 
6, 12, 13












resistance), and sul2 (sulfathiazole resistance). In EHEC and EPEC that carry the same molecular signature, 
Tn6029, or related transposon Tn6026, abuts the atypical class 1 integron precisely 24 bp into the 3´-CS. In 
strains 2009-49 and 2009-52 the mercury resistance module of Tn21 flanks one arm of the resistance region 
CRL while the other arm comprises a hybrid version of Tn1721/Tn21, that carries the tetracycline resistance 
gene tetA(A), followed by the transposition module of Tn21 (Figure 2B). The crossover region resides 373 
nucleotides upstream of the class 1 integron IRi which notably, has been reported previously in a clinical 
UPEC strain from Sydney (GenBank accession HM999791.1). The CRL is sufficient to encode resistance to 
ampicillin, streptomycin, sulfonamides, tetracycline, and trimethoprim, a pattern of resistance not 
uncommon in Australian food animal production systems 
5, 18, 19
. Nitrofurantoin resistance may be attributed 
to mutations or deletions in the chromosomal nfsA and nfsB genes. In both strains, nfsA was missing the 
terminal 302 nt and nfsB contained 10 SNPs compared to that of the nitrofurantoin sensitive (wild type +) 
strain K-12 and are sufficient to engender an nfsAB
+
 genotype in strains 2009-49 and 2009-52. 
 
3.4 pSDJ2009-52F carries the Tn1721/Tn21 hybrid transposon 
The hybrid Tn1721/Tn21 transposon is located in the repFIIa gene in pSDJ2009-52F and is flanked by 5 bp 
direct repeats indicating it, or a progenitor of it, transposed to this site. pSDJ2009-52F carries ExPEC VAGs 
that have a role in the acquisition of iron including iutA, iucDCBA, shiF, sitDCBA, hlyF, etsABC, iroBCDE, 
iroN, as well as ompT, iss and cvaC genes (Table 1). Both Sydney ST58 strains carry identical copies of 
pSDJ2009-52F. BLASTn analysis shows that the sequence flanking either side of hybrid transposon shares 
significant nucleotide sequence identity with pSF-088-1 (accession number CP012636.1), a plasmid found 
in an ST95 strain of E. coli recovered from a patient with a bloodstream infection at San Francisco General 
Hospital (Figure 2A). ST95 is a sequence type linked with ExPEC disease in poultry and humans. pSF-088-
1 but not pSDJ2009-52F contains the full tra region and lacks the tet genes of Tn1721. Notably, pSF-088-1 
carries the same atypical class 1 integron found in the uropathogenic Sydney ST58 strains.  
 
4. Conclusion 
Here we describe the isolation and sequence analysis of two E. coli ST58 phylotype B1 strains from the 












CRL encoding multiple antibiotic resistance genes, IS26, and a variety of VAGs that are typical of colV 
plasmids. ColV plasmids have been implicated in ExPEC infections in human and animals often causing 
urinary, neurological and systemic disease. pSDJ2009-52F encodes resistance to multiple classes of 
antibiotics, the genes of which are housed within a Tn2610-like hybrid Tn1721/Tn21 transposon. 
 
E. coli ST58 has been isolated from mammalian and avian hosts including European rooks, humans, cats, 
camels and cattle. In Enterobase (https://enterobase.warwick.ac.uk/species/index/ecoli), ST58 strains are 
described from a range of sources including humans, pigs, cows, horses, retail meat, animal feed, dogs, 
turkeys and various other birds, a prairie dog, goats, sheep, spinach, water and soil and various geographic 
locations including Australia, Ireland, France, Denmark, Tanzania, Ethiopia, Japan, Poland, Thailand, 
Sweden, Belgium, Canada, Spain, the Netherlands, USA, Brazil, Germany, the United Kingdom, China, and 
Bangladesh (accessed 06/06/2018). To our knowledge this is the first description of a multiple antibiotic 
resistant ST58 strain associated with both UTI and blood sepsis. Our studies provide an example of how 
acquisition of a single plasmid can impart an arsenal of virulence and antibiotic resistance genes to a 
commensal E. coli with a wide host range and suggests that the acquisition of the IncF plasmid pSD2009-
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Figure and Table legends: 
Figure 1. Proportional cladogram of all ST58 genomes from Enterobase with complete metadata according 
to our selection criteria. A black circle indicates a node value of 1.  
 
Figure 2. A) Sequence of pSDJ2009-52F as compared to pSF-088-1 via BRIG. Green/purple histogram is 
GC skew, black histogram is GC content and black bar is BLAST match with pSF-088-1. Outer ring is a 
schematic of pSDJ2009-52F created in SnapGene. Virulence-associated genes and the CRL are colour-
coded. B) Complex resistance loci found in ST58 strains 2009-49 and 2009-52. Genes are colour coded to 
coincide with those in Figure 2A. 
 



























Yersiniabactin receptor chuA 98 chromosome 
Control of copper homeostasis copA 98 chromosome 
multicopper oxidase cueO 97 chromosome 
Transcriptional regulator cueR 100 chromosome 
Copper and silver efflux  membrane component cusA 99 chromosome 
Copper and silver efflux membrane fusion protein cusB 99 chromosome 
Copper and silver efflux outer membrane protein cusC 98 chromosome 
Periplasmic copper binding protein cusF 98 chromosome 
Response regulator cusR 97 chromosome 
Histidine kinase cusS 97 chromosome 
Putative type 1 secretion membrane-fusion protein etsA 99 pSDJ2009-52F 
Putative type 1 secretion ATP binding protein etsB 99 pSDJ2009-52F 
Putative type 1 secretion outer membrane protein etsC 100 pSDJ2009-52F 
Pesticin/Yersiniabactin receptor fyuA 99 chromosome 
Iron-related glycosyltransferase iroB 100 pSDJ2009-52F 
Putative ABD transporter iroC 99 pSDJ2009-52F 
Ferric enterochelin esterase iroD 99 pSDJ2009-52F 
Siderophore esterase iroE 99 pSDJ2009-52F 
Iron outer membrane receptor iroN 100 pSDJ2009-52F 
Yersiniabactin biosynthesis irp1 99 chromosome 
Yersiniabactin biosynthesis irp2 99 chromosome 
Aerobactin biosynthesis iucA 100 pSDJ2009-52F 
Aerobactin biosynthesis iucB 100 pSDJ2009-52F 
Aerobactin biosynthesis iucC 100 pSDJ2009-52F 
Aerobactin biosynthesis iucD 99 pSDJ2009-52F 
Ferric aerobactin receptor iutA 100 pSDJ2009-52F 
Iron/manganese transport system periplasmic binding 
protein 
sitA 99 pSDJ2009-52F 
Iron/manganese transport system inner membrane 
protein 
sitB 100 pSDJ2009-52F 
Iron/manganese transport system inner membrane 
protein 
sitC 99 pSDJ2009-52F 
Iron/manganese transport system inner membrane 
protein 





Colicin V secretion protein cvaA 100 pSDJ2009-52F 
Colicin V secretion protein cvaB 99 pSDJ2009-52F 
Colicin V precursor cvaC 100 pSDJ2009-52F 
Colicin V immunity protein cvi 100 pSDJ2009-52F 
Adhesion 
Phase-variable biofilm formation autotransporter agn43 98 chromosome 
M-agglutinin subunit bmaE 100 chromosome 
Curli secretion channel csgG 98 chromosome 
Tyrosine recombinase fimB 99 chromosome 
Minor fimbrial subunit fimH 99 chromosome 
G-fimbriae gafD 99 chromosome 
putative fimbrial-like adhesin protein yfcV 98 chromosome 
Blood-
associated 
Auto-aggregating adhesin and invasion hek 98 chromosome 
Haemolysin/cytolysin hlyE 99 chromosome 
Avian haemolysin and regulator of outer membrane 
vesicle biogenesis 












Increased serum survival and resistance to 
complement 
iss 100 pSDJ2009-52F 
Other 
Outer membrane protease, regulates the biogenesis of 
outer membrane vesicles  
ompT 100 pSDJ2009-52F 
putative membrane transport protein shiF 99 pSDJ2009-52F 
Conjugal transfer surface exclusion protein traT 99 pSDJ2009-52F 
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